Researchers from the University of California San Diego have found that a novel blood-based biomarker can predict a woman's risk of developing dementia as many as 25 years before symptoms appear. The ...
(RTTNews) - BioCryst Pharmaceuticals, Inc. (BCRX) Monday reported positive results from APeX-P study of Orladeyo in hereditary angioedema (HAE) patients aged between 2 and 12 years. APeX-P study is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results